• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

RBM15介导的PERP的N6-甲基腺苷修饰通过p53信号通路增强肺腺癌的肿瘤发生。

N6-Methyladenosine Modification of PERP by RBM15 Enhances the Tumorigenesis of Lung Adenocarcinoma via p53 Signaling Pathway.

作者信息

Li Ruiying, Xia Xiaochuang, Chen Wenping, Wang Hongmin, Feng Lunda, Wang Zhouyi

机构信息

Department of Geriatrics, Huanggang Central Hospital, No.126, Huangzhou District, Huanggang, 438000, Hubei, China.

Department of Cardiovascular Medicine, Huanggang Central Hospital, Huanggang 438000, Hubei, China.

出版信息

Mol Biotechnol. 2024 Nov 18. doi: 10.1007/s12033-024-01323-2.

DOI:10.1007/s12033-024-01323-2
PMID:39556280
Abstract

The promotive effect of P53 apoptosis effector related to PMP-22 (PERP) on lung adenocarcinoma (LUAD) has been confirmed. However, the N6-methyladenosine (m6A) modification of PERP to regulate LUAD progression have not been revealed. Bioinformatic analysis predicted the mechanism of PERP interacting with RBM15 and p53 pathway using GEPIA and The Cancer Genome Atlas (TCGA) databases. The qRT-PCR, cell function experiments, and western blotting were applied to further confirm the function and mechanism of PERP and RBM15 in LUAD cells. Methylated RNA immunoprecipitation (MeRIP) and mRNA stability assays were used to reveal the interaction between PERP and RBM15 in LUAD cells. PERP with high expression in LUAD showed the poor survival. Silencing PERP prevented LUAD cells to proliferate, migrate, and invade via activating p53 pathway, whereas overexpressing PERP showed the opposite effect on LUAD cells. Mechanistically, RBM15 overexpression could promote PERP m6A modification to enhance the PERP mRNA stability. In addition, RBM15 overexpression leading to LUAD cell malignancy was reversed by PERP knockdown. This study reveals that the mA modification of PERP regulated by RBM15 enhances the tumorigenesis of LUAD by inhibiting the p53 signaling pathway, which may provide novel insights into the LUAD mechanism.

摘要

P53凋亡效应因子相关蛋白22(PERP)对肺腺癌(LUAD)的促进作用已得到证实。然而,PERP的N6-甲基腺苷(m6A)修饰在调节LUAD进展中的作用尚未见报道。利用GEPIA和癌症基因组图谱(TCGA)数据库进行生物信息学分析,预测了PERP与RBM15及p53信号通路相互作用的机制。应用qRT-PCR、细胞功能实验和蛋白质免疫印迹法进一步证实PERP和RBM15在LUAD细胞中的功能及机制。采用甲基化RNA免疫沉淀(MeRIP)和mRNA稳定性检测来揭示LUAD细胞中PERP与RBM15的相互作用。PERP在LUAD中高表达提示患者预后不良。沉默PERP可通过激活p53信号通路抑制LUAD细胞的增殖、迁移和侵袭,而过表达PERP则对LUAD细胞产生相反的作用。机制上,RBM15过表达可促进PERP的m6A修饰,增强PERP mRNA的稳定性。此外,PERP敲低可逆转RBM15过表达导致的LUAD细胞恶性表型。本研究揭示了RBM15调控的PERP的m6A修饰通过抑制p53信号通路增强LUAD的肿瘤发生,这可能为LUAD的发病机制提供新的见解。

相似文献

1
N6-Methyladenosine Modification of PERP by RBM15 Enhances the Tumorigenesis of Lung Adenocarcinoma via p53 Signaling Pathway.RBM15介导的PERP的N6-甲基腺苷修饰通过p53信号通路增强肺腺癌的肿瘤发生。
Mol Biotechnol. 2024 Nov 18. doi: 10.1007/s12033-024-01323-2.
2
RBM15 facilities lung adenocarcinoma cell progression by regulating RASSF8 stability through N6 Methyladenosine modification.RBM15通过N6甲基腺苷修饰调节RASSF8稳定性促进肺腺癌细胞进展。
Transl Oncol. 2024 Aug;46:102018. doi: 10.1016/j.tranon.2024.102018. Epub 2024 Jun 4.
3
RBM15 drives the progression of lung adenocarcinoma by regulating N6-methyladenosine-mediated LDHA mRNA stability.RBM15 通过调控 N6-甲基腺苷介导的 LDHA mRNA 稳定性促进肺腺癌的进展。
Life Sci. 2024 Dec 1;358:123146. doi: 10.1016/j.lfs.2024.123146. Epub 2024 Oct 13.
4
The prognostic value of N6-methyladenosine RBM15 regulators in lung adenocarcinoma.N6-甲基腺苷 RBM15 调节因子在肺腺癌中的预后价值。
Cell Mol Biol (Noisy-le-grand). 2022 May 22;68(1):130-139. doi: 10.14715/cmb/2022.68.1.17.
5
Gene amplification-driven RNA methyltransferase KIAA1429 promotes tumorigenesis by regulating BTG2 via m6A-YTHDF2-dependent in lung adenocarcinoma.基因扩增驱动的 RNA 甲基转移酶 KIAA1429 通过 m6A-YTHDF2 依赖途径调节 BTG2 促进肺腺癌的发生。
Cancer Commun (Lond). 2022 Jul;42(7):609-626. doi: 10.1002/cac2.12325. Epub 2022 Jun 21.
6
RBM15 Knockdown Impairs the Malignancy of Cervical Cancer by Mediating m6A Modification of Decorin.RBM15基因敲低通过介导核心蛋白聚糖的m6A修饰来损害宫颈癌的恶性程度。
Biochem Genet. 2025 Feb;63(1):225-238. doi: 10.1007/s10528-024-10757-x. Epub 2024 Mar 1.
7
RBM15 facilitates laryngeal squamous cell carcinoma progression by regulating TMBIM6 stability through IGF2BP3 dependent.RBM15 通过 IGF2BP3 依赖性调节 TMBIM6 的稳定性促进喉鳞状细胞癌的进展。
J Exp Clin Cancer Res. 2021 Feb 26;40(1):80. doi: 10.1186/s13046-021-01871-4.
8
METTL3 exerts synergistic effects on m6A methylation and histone modification to regulate the function of VGF in lung adenocarcinoma.METTL3 通过协同作用调控 m6A 甲基化和组蛋白修饰来调节 VGF 在肺腺癌中的功能。
Clin Epigenetics. 2023 Sep 23;15(1):153. doi: 10.1186/s13148-023-01568-9.
9
KIAA1429 Induces m6A Modification of LINC01106 to Enhance the Malignancy of Lung Adenocarcinoma Cells via the JAK/STAT3 Pathway.KIAA1429 通过 JAK/STAT3 通路诱导 LINC01106 的 m6A 修饰来增强肺腺癌细胞的恶性程度。
Crit Rev Immunol. 2024;44(6):49-61. doi: 10.1615/CritRevImmunol.2024052728.
10
PERP May Affect the Prognosis of Lung Adenocarcinoma by Inhibiting Apoptosis.PERP可能通过抑制细胞凋亡影响肺腺癌的预后。
Cancer Manag Res. 2024 Mar 20;16:199-214. doi: 10.2147/CMAR.S443490. eCollection 2024.

引用本文的文献

1
Targeting PERP promotes anti-tumor immunity in HNSCC by regulating tumor immune microenvironment and metabolic homeostasis.靶向 PERP 通过调节肿瘤免疫微环境和代谢稳态促进头颈部鳞状细胞癌的抗肿瘤免疫。
Mol Cancer. 2025 Jun 7;24(1):168. doi: 10.1186/s12943-025-02360-4.

本文引用的文献

1
CALU promotes lung adenocarcinoma progression by enhancing cell proliferation, migration and invasion.CALU 通过增强细胞增殖、迁移和侵袭促进肺腺癌的进展。
Respir Res. 2024 Jul 5;25(1):267. doi: 10.1186/s12931-024-02901-3.
2
PERP May Affect the Prognosis of Lung Adenocarcinoma by Inhibiting Apoptosis.PERP可能通过抑制细胞凋亡影响肺腺癌的预后。
Cancer Manag Res. 2024 Mar 20;16:199-214. doi: 10.2147/CMAR.S443490. eCollection 2024.
3
Enhancement of TKI sensitivity in lung adenocarcinoma through m6A-dependent translational repression of Wnt signaling by circ-FBXW7.
通过 circ-FBXW7 介导的 m6A 依赖的翻译抑制作用增强肺腺癌对 TKI 的敏感性。
Mol Cancer. 2023 Jul 1;22(1):103. doi: 10.1186/s12943-023-01811-0.
4
Lung Cancer Screening in Asia: An Expert Consensus Report.《亚洲肺癌筛查:专家共识报告》
J Thorac Oncol. 2023 Oct;18(10):1303-1322. doi: 10.1016/j.jtho.2023.06.014. Epub 2023 Jun 28.
5
The Proteins of mRNA Modification: Writers, Readers, and Erasers.mRNA 修饰蛋白:书写者、阅读者和擦除者。
Annu Rev Biochem. 2023 Jun 20;92:145-173. doi: 10.1146/annurev-biochem-052521-035330. Epub 2023 Apr 17.
6
mRNA Regulation by RNA Modifications.mRNA 修饰的调控作用。
Annu Rev Biochem. 2023 Jun 20;92:175-198. doi: 10.1146/annurev-biochem-052521-035949. Epub 2023 Apr 5.
7
DCAF13 promotes breast cancer cell proliferation by ubiquitin inhibiting PERP expression.DCAF13 通过泛素抑制 PERP 表达促进乳腺癌细胞增殖。
Cancer Sci. 2022 May;113(5):1587-1600. doi: 10.1111/cas.15300. Epub 2022 Mar 18.
8
p53 signaling in cancer progression and therapy.p53信号通路在癌症进展与治疗中的作用
Cancer Cell Int. 2021 Dec 24;21(1):703. doi: 10.1186/s12935-021-02396-8.
9
NPM1 Is a Prognostic Biomarker Involved in Immune Infiltration of Lung Adenocarcinoma and Associated With m6A Modification and Glycolysis.NPM1 是肺腺癌免疫浸润的预后生物标志物,与 m6A 修饰和糖酵解有关。
Front Immunol. 2021 Jul 16;12:724741. doi: 10.3389/fimmu.2021.724741. eCollection 2021.
10
PHLDA3 promotes lung adenocarcinoma cell proliferation and invasion via activation of the Wnt signaling pathway.PHLDA3 通过激活 Wnt 信号通路促进肺腺癌细胞的增殖和侵袭。
Lab Invest. 2021 Sep;101(9):1130-1141. doi: 10.1038/s41374-021-00608-3. Epub 2021 May 18.